Assignee
BELHAVEN BIOPHARMA INC
US·8 granted patents·7 pending applications·15 citations·filing 2022–2025
Top patents by PatentIndex Score
15 records- 0194US11433063B1Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticidesBELHAVEN BIOPHARMA INC·Filed 2022·Granted Sep 6, 2022·5 cites·20 claims
- 0293US11872308B2Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2023·Granted Jan 16, 2024·3 cites·20 claims
- 0393US11617716B2Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2022·Granted Apr 4, 2023·3 cites·20 claims
- 0491US12414916B2Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2023·Granted Sep 16, 2025·1 cites·15 claims
- 0591US12097287B2Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2024·Granted Sep 24, 2024·1 cites·20 claims
- 0689US12005185B2Medical counter measures including dry powder formulations and associated methodsBELHAVEN BIOPHARMA INC·Filed 2022·Granted Jun 11, 2024·1 cites·20 claims
- 0788US12102629B1Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticidesBELHAVEN BIOPHARMA INC·Filed 2022·Granted Oct 1, 2024·1 cites·20 claims
- 0882US2026076897A1Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0982US2025000792A1Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1079US2026007594A1Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1173US2024299680A1Medical counter measures including dry powder formulations and associated methodsBELHAVEN BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1258US2024148990A1Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1352US2024100272A1Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1448US12502498B1Compositions, devices, and methods for intranasal delivery of dry powder epinephrineBELHAVEN BIOPHARMA INC·Filed 2025·Granted Dec 23, 2025·0 cites·20 claims
- 1546US2026021042A1Dry powder formulations of epinephrine and associated methodsBELHAVEN BIOPHARMA INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BELHAVEN BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →